Surrogate Markers - YouTube
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
Surrogate markers for GHB exposure in cell lines / 978-3-330-03856-1 / 9783330038561 / 333003856X
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Imaging as a surrogate marker of drug efficacy in cardiovascular disease | Heart
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Diagnostics | Free Full-Text | Circulating Monocyte Count as a Surrogate Marker for Ventricular-Arterial Remodeling and Incident Heart Failure with Preserved Ejection Fraction
Surrogate Markers - TriageMethod
JAHA on Twitter: "New study shows that fractional excretion of urea nitrogen could be a novel surrogate marker of volume status in patients with requiring diuretics. https://t.co/Uk4jUhune2 @TomokiOchiai #AHAJournals https://t.co/9CKo9DxpWm" / Twitter
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Controlling HgBA1C with Medications Does not Make Diabetes Disappear - It Lowers the Surrogate Marker HgBA1C - APIM
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
Surrogate endpoints in clinical trial
2 Review: Evaluating and Regulating Biomarker Use | Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease |The National Academies Press
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer | Scientific Reports
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Appendix D: Biomarkers Figure | Sodium Intake in Populations: Assessment of Evidence |The National Academies Press
